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Congenital Portosystemic Shunts in
the Canine: A Case Report and
Review of the Syndrome, Its
Diagnosis and Treatment
Tamara Boettcher, DVM*
Dale L. Rigg, DVM, MS**
INTRODUCTION
Congenital anomalies of the portal vascular
system which result in blood bypassing the he-
patic parenchyma lead to the development of
hepatic insufficiency. Most commonly seen in
young dogs (mean age at onset of clinical signs
in one report was 8.4 months l ), cases of porto-
systemic shunts are characterized by a wide va-
riety of clinical and pathologic abnormalities.
The portal vein is formed by the confluence
of the splenic and cranial mesenteric veins at
the level of the second lumbar vertebra. 2 It col-
lects the blood from the stomach, intestines,
pancreas and spleen. In all, two-thirds of the
blood supply to the liver comes from the portal
vein. 3
The investigation of correlation between he-
patic function and portal blood supply was ini-
tially based on surgical anastomosis of the por-
tal vein to the caudal vena cava (Eck's fistula).
Reports of naturally occurring portosystemic
shunts are increasing due to a higher incidence
of the syndrome and/or an increased awareness
by veterinary practitioners. A case report of
congenital portosystemic shunting is presented
here with a discussion of possible pathogenesis,
radiography, clinical pathology and treatment
regimens.
CASE REPORT
On June 2, 1982, a 5 lb., 21f2-year-old fe-
male Yorkshire terrier was referred to the ISU
Veterinary Teaching Hospital. Presenting
problems included pacing, restlessness and ap-
parent blindness. The dog had been vaccinated
for distemper, parvovirus, leptospirosis, canine
adenovirus II and rabies.
Between October 1980 and March 1981 the
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dog had several episodes of tonsillitis accompa-
nied by vomiting, occasional diarrhea and oc-
casional itching. A tonsillectomy was per-
forn1ed March 19, 1981. From August 1981 to
January 1982 there were further episodes of
vomiting, diarrhea and itching. The condition
seemed to respond to antibiotics and steroids.
On April 13, 1982 the dog had a bout of
vomiting, and diarrhea with only partial re-
sponse to therapy. The animal was restless and
continuously paced the floor. Vomiting contin-
ued with gagging and anorexia. No significant
abnormalities were seen radiographically.
On presentation to ISU the dog was restless,
had eaten some food but exhibited no vomit-
ing, and had feces of normal consistency. The
dog had lost two pounds over a period of
several weeks and appeared emaciated. Slight
proprioceptive deficits were apparent in all
four limbs. The dog was hospitalized and
blood and urine samples were taken for analy-
sis. Significant abnormalities included hypo-
calcemia (8.7 mg/dl), hypoalbuminemia (2.8
g/dl), low normal BUN (11 mg/dl) and slightly
increased SGPT (79.3 lUlL). There was also a
relative polycythemia and decreased numbers
of platelets. Urinalysis showed a triple phos-
phate crystalluria.
An an1monia tolerance test was performed
on the following day. An abnormal increase in
venous blood ammonia was noted after ad-
ministration of ammonium chloride orally.
Fasting venous blood ammonia was 150 ug/dl
while 30 minutes post-administration the level
was 241 ugldl. A tentative diagnosis of hepatic
insufficiency was made based on these findings.
A portosystemic shunt was suspected.
On June 4, 1982 the dog was sent home on
a restricted protein diet of rice and cottage
cheese. The owner was informed of the poor
prognosis with medical management alone.
On June 8, the dog was readmitted to the
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clinic for operative portal venography. Anes-
thesia was induced with methoxyflurane ad-
ministered via face mask. A ventral midline
laparotomy was performed and a jejunal me-
senteric vein was catheterized using a 22 gauge
intravenous catheter. Survey radiographs were
taken and then 2 cc of contrast mediuma was
hand-injected. Four lateral projection radio-
graphs were taken at 0.5 second intervals. A
single ventrodorsal (V-D) view was taken fol-
lowing a second injection of 2 cc of contrast
medium.
Both lateral and V-D projections showed a
large central venous shunt from the origin of
the portal vein to the caudal vena cava in a
post-hepatic location. The shunt was larger in
diameter than the cranial portion of the portal
vein in the lateral view. There was no evidence
of opacification of the normal portal vein and
its hepatic branches within the liver.
Following return to surgery and exploration
of the craniodorsal abdomen, the shunt vessel
could be seen extending dorsally from the por-
tal vein to the caudal vena cava, cranial to the
renal veins. The shunt was temporarily ob-
structed and observation of the intestinal serosa
and mesenteric veins for 10 minutes revealed
no signs of congestion. Radiography was per-
formed following complete occlusion of the
shunt. Lateral and V-D views showed filling of
the remainder of the portal vein with evidence
of branching of vessels into the hepatic paren-
chyma. The V-D view showed well-defined
vessels in the area of the right medial and lat-
eral lobes as well as the caudate lobe of the
liver. Vessels supplying the left medial and lat-
eral liver lobes were poorly opacified and lack-
ed arborization.
Complete ligation of the shunt was per-
formed, the mesenteric catheter was removed
and the area of the venipuncture ligated. Rou-
tine closure of the abdomen was performed
and the dog was allowed to recover from anes-
thesia under close observation. She was sent
home June 10 with a steadily improving ap-
petite. The owners reported problems with
vomiting late at night but this was alleviated
when the feeding schedule was changed to
feeding throughout the day and night. At last
report the dog had gained about 2 Ibs. and was
bright, alert and energetic.
aHypaque-M75R , Winthrop Lab., New York, New
York.
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DISCUSSION
Five major types of naturally occurring por-
tosystemic anomalies have been recognized:
(1) patent ductus venosus, (2) atresia of the
portal vein with development of accessory por-
tosystemic shunts, (3) anomalous connection of
the portal vein to the caudal vena cava, (4)
anomalous connection of the portal vein to the
azygous vein, and (5) anomalous connection of
the portal vein and caudal vena cava to the
azygous vein.4
CLINICAL SIGNS
Clinical signs associated with portosystemic
shunts are related to hepatic insufficiency due
to altered composition of blood flow to the
liver. Neurologic abnormalities are common
and include listlessness, depression, com-
pulsive pacing or circling, head pressing, atax-
ia, seizures, sudden viciousness, staring, blind-
ness, hyperrnetria, tremors, coma or stupor.
Stunted growth, weight loss and gastrointes-
tinal disorders including vomiting, diarrhea,
hypersalivation and anorexia can be seen. As-




Blood analysis usually reveals slight to mod-
erate elevations of SGPT and SAP, increased
numbers of leukocytes (usually due to neu-
trophilia), low cholesterol, increased serum bi-
1irubin and hypoproteinemia.
Anemia, commonly seen in Eck's Fistula
dogs,4 has not been associated with congenital
portosysten1ic shunts in most cases, although
Griffiths, et al. did find a significant correlation
between erythrocyte microcytosis and porto-
systemic shunts, which may be related to ane-
mia in some dogs. 5
Hypokalemia can often be found especially
in cases exhibiting hepatic encephalopathy. 6,7
Blood urea nitrogen levels are usually low to
below normal. 8
Urinalysis will often lead to the detection of
ammonium biurate crystals. Increased serum
ammonia and concentration of the urine con-
tribute to this significant finding. 6 Some re-
ports of urate crystalluria have also been
made. 9 These have not yet been found in por-
tosystemic shunts in cats.
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PATHOGENESIS
Hepatic function appears to be dependent
on portal blood composition rather than total
blood flow. Attempts to increase arterial blood
supply in congenital shunt cases have not alle-
viated clinical signs. 10 An essential hepato-
trophic portal blood factor has been reported.
Research indicates this factor may be produced
by the pancreas, involving glucagon and/or in-
sulin. 11,12
The neurologic abnormalities associated
with hepatic insufficiency have been referred to
as hepatic encephalopathy (HE). Portal vascu-
lar anomalies are just one of a number of disor-
ders that can produce this syndrome.
Numerous toxins have been incriminated in
the pathogenesis of HE including ammonia,
mercaptans, short chain fatty acids, false
neurotransmitters (octapamine, gamma-
amino-butyric acid, beta-phenylethano-
lamines) and increased plasma concentrations
of the aromatic amino acids phenylalanine,
tyrosine and tryptophan. Some researchers feel
that the syndrome is actually a combination of
several of these factors. 10,13,14
Much emphasis has been placed on the role
of ammonia in HE. Gastrointestinal (GI) pro-
duction of ammonia is a primary source.
Many bacterial species that reside in the G I
tract are capable of hydrolyzing urea by way of
the enzyme urease. This enzyme has been de-
termined to be exclusively of bacterial origin. 7
Bacterial metabolism of ingested protein and
products of protein digestion or urea, produce
40 percent of the G I ammonia while the re-
mainder comes from non-bacterial sources in-
cluding dietary ammonia and protein. Addi-
tional ammonia comes from the kidney, liver,
muscle, nerve tissue, brain and erythrocytes. 15
Ammonia is removed from the blood and
tissues by intrahepatic urea formation and ex-
trahepatic amination of ketoacids. 16 Ammonia
uptake by the liver is related to the blood flow.
Aldrete, et al. determined that 13 to 19 percent
of the ammonia reaching the liver of dogs with
experimental portacaval transposition by-
passed metabolism to urea and re-entered the
circulation as measurable ammonia. 16
Movement of ammonia into and out of the
vascular system is a very rapid process and
conversion into glutamine in the body tissues
can be completed within seconds. Body cells
are freely permeable to ammonia but are al-
most impermeable to ammonium ion. Relative
amounts of each are determined by pH (being
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in equilibrium, NH3 + H+ ~ NH:). At the
physiologic pH of 7.4 almost all of the ammo-
nia of the blood is in the ionized form. 15 Meta-
bolic alkalosis associated with hypokalemia will
shift the equilibrium toward the more toxic,
free NH3.6,7
There are several theories to account for the
toxicity of ammonia in the brain including in-
terference with brain energy metabolism, accu-
mulation of the inhibitory neurotransmitter
GABA, a decrease in the neurotransmitter ace-
tylcholine, a direct inhibitory effect on the
neuronal membrane and a toxic intermediary
metabolite. 17,18 Of these, interference with
brain energy metabolism appears to warrant
the most support. 14 ,18
Inability to correlate the magnitude of hy-
perammonemia with the degree of encephalop-
athy has stimulated interest in a second impor-
tant theory as to the cause ofCNS dysfunction.
Specific amino acid patterns have been found
to be present in the blood of animals with
HE. 13 ,17,19,20,21 The plasma concentrations of
branched chain amino acids (BCAA) valine,
leucine and isoleucine have been found to be
lower than normal in dogs with portosystemic
vascular anastomosis, whereas the aromatic
amino acids (phenylalanine, tyrosine and try-
ptophan) are found in increased concentra-
tions. In the normal dog the ratio of branched
chain to aromatic amino acids is greater than 3
while with HE the ratio has been found to be
about 1-11fz. 13,17,19
The low concentrations of BCAA are
thought to be due to increased utilization by
muscle and adipose tissue for energy. 5,19,22
There is controversy over the reason for the
increased utilization. Some believe it is pro-
moted by increased serum insulin stimulating
uptake and catabolism of BCAA by muscle, 19
while others relate it to glucagon release asso-
ciated with hyperamn'lonemia (glucagon pro-
moting gluconeogenesis from amino acids).13,20
Hyperglucagonemia, hyperinsulinemia, hy-
perglycemia and decreased concentrations of
BCAA have been seen in normal dogs to which
ammonium chloride was administered. 20
Impaired hepatic metabolism of the aro-
matic an'lino acids is the most likely cause of
their increased plasma concentrations.
Branched chain and aromatic amino acids
compete for transport into the brain. De-
creased concentrations of BCAA would allow
more of the aromatic amino acids to be trans-
ported. These may impair cerebral catechol-
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amine metabolism, causing an increased syn-
thesis of serotonin (tryptophan being a direct
precursor of serotonin) and decreased synthesis
of norepinephrine (due to excess phenylalanine
which inhibits tyrosine-3-hydroxylase and al-
lows tyrosine to be converted to octapamine, a
false neurotransmitter).t3,t9,20
It is probable that the G I signs are also due
to the accumulation of toxins in the brain, but
this is unsupported as yet.
Ascites and edema are a result of the transu-
dation of fluid associated with decreased plas-
ma oncotic pressure due to hypoproteinemia.
The liver is the sole source of plasma albumin
and fibrinogen and hypoalbuminemia is a con-
sistent finding in cases of portosystemic shunt-
ing.6,8
DIAGNOSIS
Specific testing of hepatic function can be an
aid to evaluation of disease involving the liver.
Three types of tests are useful: (1) those that
measure serum enzyme activity, (2) those that
measure bilirubin or organic dye secretion and
excretion, and (3) those that measure a specific
metabolic function such as synthesis of plasma
proteins. 23
The most important serum enzymes in he-
patic disease are serum glutamic pyruvic tran-
saminase (SGPT, recently referred to as
alanine amino transferase) and serum alkaline
phosphatase (SAP). 23 SGPT is liver specific in
the dog and cat although small amounts do
exist in kidney and heart muscle, so moderate
increases can occur with severe renal or cardiac
disease. 24 Increased SGPT is usually indicative
of hepatocellular necrosis and inflammation.
Slight to moderate elevations are seen in cases
of portosystemic shunting.
SAP is actually a group of serum isoenzy-
mes derived from several different body tis-
sues. 25 The highest levels are found in the liver,
kidney, bone, intestine and placenta, and in-
creased serum levels are usually associated with
obstruction of bile outflow and increased pro-
duction. Portosystemic shunting produces
slight to moderate elevations in SAP. Increased
SAP levels can also result from bone abnormal-
ities such as osteosarcoma or secondary hyper-
parathyroidism. It may also be a normal find-
ing in growing dogs of large breeds. 23 SAP
determinations are not useful in the cat as the
liver concentration of SAP in cats is less than
25 percent of that in dogs. 23
Bromsulphthalein (BSP) is an organic dye
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that is normally excreted in bile after conjuga-
tion with glutathione within hepatocytes. 3 Re-
tention of dye is measured 30 or 45 minutes
after I.V. injection. In normal dogs, BSP re-
tention is less than five percent. Cases with
portal venous anomalies generally have an in-
creased retention.
BSP binds to albumin in the blood following
injection. This may be important in assessing
liver function in hypoproteinemic animals.
Prolonged BSP retention due to decreased he-
patic function may be offset by increased excre-
tion due to decreased protein binding and may
result in an apparently normal BSP clear-
ance. 26 ,27
The ammonia tolerance test (ATT) is a
method of determining the liver's ability to
convert ammonia to urea. In this test, an am-
monium salt is administered orally after a 12
hour fast. Venous blood samples are taken
prior to administration of the salt and again 30
minutes after administration. In normal dogs
there is no significant increase in venous blood
ammonia from the fasting state to 30 minutes
post-administration. Dogs with portosystemic
shunting will exhibit marked and significant
rises in blood ammonia levels. Fasting venous
blood ammonia levels alone may be greatly ele-
vated. The ATT may be a more sensitive test
of altered hepatic function than BSP retention,
as cases have been found with normal BSP re-
tention but with increased blood ammonia
levels. 28 Cats may be more sensitive to oral am-
monium chloride than dogs, as one cat exhib-
ited signs of HE after administration. 29
Abnormally low serum cholesterol levels
have been found, presumably because the liver
is the main source. 30 Blood urea nitrogen levels
are usually low probably due to decreased urea
cycle activity in the liver.8
RADIOGRAPHY
Survey radiographs may be helpful for a
tentative diagnosis of congenital portal vein
anomalies, although their usefulness may be
limited by the lack of natural intra-abdominal
contrast in young or emaciated dogs. A small
liver is a common finding. Direct visualization
of the liver may be impossible but size can be
evaluated indirectly by locating gas within the
lumen of the stomach and cranial duodenal
flexure. Normally the stomach shadow lies
parallel to the ribs in the lateral view, whereas,
if the liver is small, the stomach will be more
vertical in orientation, lying unusually close to
83
Fig. 1. Pre-ligation portal venogram
Fig. 2. Post-ligation portal venogram
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the diaphragm. 4
In cases where intra-abdominal contrast is
poor, oral barium sulfate may be given to opac-
ify the stomach and duodenum and thus out-
line the caudal border of the liver.
Renal enlargement has been reported in
dogs with shunts. 4,30-32 The reason behind this is
unknown.
Contrast radiography is extremely useful in
the diagnosis of shunts. Cranial mesenteric ar-
terial portography (CMAP), splenoporto-
graphy, and portography have been found to
be the most useful.
Selective catheterization of the visceral aor-
tic branches, most commonly the cranial me-
senteric artery permits the portal system to be
outlined during the venous phase of an arterial
injection of contrast medium. 31 This is per-
formed under general anesthesia via a femoral
artery cutdown, placing the catheter under
fluoroscopic monitoring. Quality of CMAP
may be inconsistent as it requires delivery of a
large quantity of the contrast medium to the
venous system as a bolus. Problems can occur
if the contrast medium is injected too fast and
under too much pressure, as regurgitation of
the contrast into the abdominal aorta can occur
and result in a poor quality study. 31 Catheter
slippage from the artery (due to force of injec-
tion) can also occur leading to a non-selective
aortogram. Delayed passage of contrast me-
dium can lead to dilution and poor vascular
contrast. It has been reported that improved
quality may be seen if injections of vasodila-
tors, such as prostaglandin E 1 , 33 or epinephrine
are given before administration of the contrast
medium. 31
The venous phase of arterial portography
has been reported to be poor. A problem has
been superimposition due to retention of con-
trast in the gastric, splenic or hepatic capillary
beds thus preventing visualization of the sites
of drainage of the gastrosplenic and gastro-
duodenal veins.
More consistent visualization of the portal
system is obtained with splenoportography
than with arterial portography. This technique
is performed best under general anesthesia
with the dog in right lateral recumbency. A
catheter is passed obliquely into the splenic pa-
renchyma via a small skin incision while the
spleen is palpated externally. The catheter is
positioned so as to lie near to the hilus of the
spleen, thus allowing maximum venous drain-
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age of contrast medium. Fluoroscopic moni-
toring is important for proper positioning. 34
Lack of experience with this technique can lead
to accidental puncture of other abdominal or-
gans, splenic laceration and hemorrhage or
catheter slippage from the splenic parenchyma.
Contrast medium seepage into the peritoneal
cavity can interfere with maximal visualization
of abdominal detai1. 34 Shunts from the mesen-
teric venous system to the systemic circulation
cannot be seen with this technique. In cats,
splenoportography is best performed during la-
parotomy as the spleen can not be adequately
localized by palpation. 34 The splenic vein can
be catheterized during laparotomy in the dog
also.
Operative mesenteric portography is a more
invasive procedure than percutaneous angio-
graphy or splenography requiring general an-
esthesia and a laparotomy. 31,34 A catheter is
placed in a mesenteric vein and sutured in
place. The abdomen is temporarily closed for
the contrast studies and then is re-opened to
remove the catheter. The vein is ligated after
the catheter is removed. An advantage to this
procedure is that surgical ligation of the shunt
can be performed while the abdomen is open,
if contrast studies deem it to be feasible. Also,
fluoroscopy is not required. The quality of this
study is limited by the speed of injection of
contrast, which is in turn limited by the size of
catheter used. Dilution of the contrast is likely
if it is injected too slowly. Ligation of the me-
senteric vein can result in venous stasis and
possible thrombosis. 34
Other methods of contrast radiography have
been developed which may be useful in
diagnosing portal vein anomalies, but the ones
mentioned here appear to be the most com-
monly used.
Contrast radiography has been used to help
determine the feasibility of congenital porta-
caval shunt ligation by examining the circula-
tion to the liver. The absence of portal vein
branches entering the liver would prohibit any
surgical correction. But several researchers
have determined that the inability to visualize
any portal parenchymal circulation may not be
due to the absence of such circulation, but
rather to the preferential flow of blood through
the less resistant shunt. 29,35 Selective shunt oc-




Animals that present with acute hepatic en-
cephalopathy should be completely withdrawn
from oral and parenteral protein sources. In-
travenous fluids should be administered to cor-
rect dehydration and dilute toxins, correct al-
kalosis or hypokalemia and enhance renal
elimination of toxins. Ringer's solution is pre-
ferred over lactated Ringer's due to the alka-
linizing effect of the latter. Intravenous glucose
and fructose may be useful as energy sources to
prevent protein catabolism and the associated
ammonia production.3,6 Fluids are contraindi-
cated in cases with ascites.
Management of ascites may involve the use
of diuretics, however the patient must be ob-
served for hypokalemia, alkalosis and hypovo-
lemia when they are used. 22
Blood transfusions are contraindicated and
GI bleeding must be controlled as these can
increase the hyperammonemia. 17 ,22
Warm water enemas are indicated to clear
the colon of nitrogenous products and urease-
producing bacteria. Oral administration of
neomycin or kanamycin, which are classified
as gut sterilizers due to insignificant absorp-
tion, also help reduce enteric bacterial num-
bers. 24
Encephalopathic effects may be reduced by
oxygen therapy since the hepatoencephalo-
pathic brain has been found to be more sensi-
tive to hypoxia and electrolyte imbalances.3
This will also correct any renal or hepatic hy-
poxia and decrease enterohepatic circulation of
urea nitrogen. 17
Convulsions appear to be most responsive to
low dosages of diazepam (Valium) and chlor-
diazepoxide (Librium). 24
Barbiturates and tranquilizers should be
avoided due to impaired metabolism by the
liver and increased sensitivity of the brain, thus
potentiating their duration of action and toxic-
ity.4,21,30,36
Intravenous antibiotics may be indicated for
concurrent infections. Chloramphenicol or so-
dium penicillin (alone or in combination with
kanamycin) have been recommended. 17
If analgesia is required, reduced dosages of
meperidine, codeine or acetaminophen are rec-
ommended over morphine. 24
LONG-TERM
MEDICAL MANAGEMENT
Although the usual course for management
of shunts has been medical, the success of such
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therapy has been poor. Progressive deteriora-
tion due to hepatic fibrosis and atrophy has
been the rule. 4,6
Oral protein intake must be restricted.
Small ~mounts of protein with high biologic
value (percentage of protein absorbed and re-
tained) should be fed frequently throughout the
day. These will be maximally catabolized be-
fore they reach the large intestine thus prevent-
ing action by the urea-splitting bacteria. Pro-
teins of animal origin are better than those of
plant origin as the latter are often deficient in
lysine, methionine, leucine and tryptophan. 37
Recommended proteins are eggs and cottage
cheese. Fish meal, shellfish and animal gland
products should be restricted as they contain
purine and precursors of uric acid. 37
Restoring plasma concentrations of BCAA
may be important in treatment. Parenteral
supplementation with specific mixture of syn-
thetic amino acids has been used to correct im-
balances. 13 Cottage cheese appears to provide
an unidentified substance that has been found
to aid cases of HE, besides being a rich source
of BCAA. 19,38 However, its usefulness is limited
as dogs don't readily accept it.
The carbohydrate source is also an impor-
tant consideration. The diet should contain a
high level of carbohydrates which are com-
pletely digestible within the small intestine.
This is important as metabolism to volatile fat-
ty acids (VFA) can occur within the colon, and
VFA have been found to be synergistic with
hyperammonemia in producing the signs of
HE. 37 Starch and dextrose from rice and corn
syrup are readily available sources of energy.
Energy sources must be correlated to pro-
tein intake to prevent energy deficits. In
energy deficits, BCAA are utilized for energy,
further depleting their plasma concentrations. 37
Vitamin supplementation is warranted since
the liver's ability to store and convert them to
the biologically active compounds is impaired.
Long-term oral antibiotics have been recom-
mended to decrease the colonic content of
urea-splitting bacteria. Neomycin has been
commonly used. However, because severe re-
nal insufficiency may develop in the late stages
of hepatic failure, treatment with neomycin
must be carefully monitored because' of ototox-
icity or further injury to the kidneys, even with
oral administration.
If ascites is a problem, a low sodium diet
and judicious use of diuretics may be war-
ranted. An oral potassium supplement may be
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used to avoid hypokalemia. 17
Lactulose (beta-1, 4-galactoside fructose) is a
non-absorbable synthetic disaccharide which
has been used in cases of portal vein anomalies
which are unresponsive to protein restriction
and oral neomycin. It is given orally and is
hydrolyzed in the colon to lactic, formic and
acetic acids which produce an acid environ-
ment and shift the NH3 + H+ ~ NHZ equilib-
rium away from ammonia. The acid environ-
ment favors the growth of Lactobacillus
organisms which do not split urea. 17 ,29 Lactu-
lose also acts as a cathartic, decreasing intes-
tinal contact time and thus decreasing the
amount of ammonia produced. Side effects as-
sociated with its use include anorexia, vomit-
ing, diarrhea, abdominal pain and flatulence. 17
Methionine has been used because of its
lipotropic properties, however, caution is indi-
cated as it is metabolized to mercaptans within
the intestine. These may be synergistic with
ammonia in producing hepatic coma. 3,7,22
Anabolic steroids have been shown to de-
crease protein catabolism and improve liver
function in man if administered over long pe-
riods of time. However, it is very important
that adequate protein and energy be available
for optimum action. 24
L-dopa has been used in experimentally
created portacaval shunt cases and may de-
crease blood ammonia. It may replace false
neurotransmitters and thus be a protection
against hepatic encephalopathy.17
SURGICAL TREATMENT
Surgical ligation of congenital portosysten1ic
shunts has recently gained some support in the
literature. If contrast radiography reveals he-
patic circulation and one or a few shunt ves-
sels, ligation may be feasible. Ligation of ac-
quired shunts should not be attempted.
A significant determinant of the success of
ligation in a patient is measurement of portal
venous pressure. Normal portal venous pres-
sure in the dog is 8 -12 em. H 20. 29,30 Rapid
marked increases in pressure after occlusion of
the shunt indicate that subtotal ligation should
be considered rather than complete ligation.
Temporary occlusion of the shunt over
several minutes while observing the viscera for
signs of venous congestion and engorgement
can be useful if a manometer is not available
for determining pressure. However, Breznock
reported two cases of complete shunt ligation
where stagnant hypoxia of the viscera was not
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noted until three to five hours after occlusion. 30
Subtotal ligation of shunts in very young
dogs may gradually lead to total occlusion as
the relative size of the lumen decreases with
age. 35 In older dogs a second procedure at a
later date to further decrease the size of the
lumen may be possible as hepatic portal circu-
1ation increases.
Strombeck, et al. attempted total surgical li-
gation of a shunt vessel in combination with
arterialization of the liver by transposition of a
section of jejunum, but this failed. 10
Preparation of the patient for surgery neces-
sitates careful use of drugs due to impaired
liver function. Therefore a good anesthetic
protocol would include narcotic premedication
(reversible with naloxone) and mask induction
preferably with a mixture of methoxyflurane,
nitrous oxide and oxygen. Halothane has been
found to be hepatotoxic in combination with
hypoxia and metabolic acidosis. 24
Consideration of hepatic dysfunctions would
lend support to glucose administration during
surgery and possibly administration of plasma
proteins before anesthesia, if serum levels of
albumin are very low.
SUMMARY
The involvement of the liver in maintaining
homeostasis in multiple body systems makes
diagnosis and treatment of liver disease im-
perative for life. A wide variety of clinical signs
can occur with liver disease. Many tests of he-
patic function are available to the veterinarian
to confirm or supplement clinical impressions.
This suggests that no single test is sufficient for
diagnosis of a liver disorder. A simple screen-
ing panel (i.e., complete blood count, BUN,
SGPT, SAP, Albumin, Cholesterol, Bilirubin
and Glucose) should be done initially, and tests
subsequent to this should build upon its re-
sults. The ATT and BSP retention have
proven very useful. Contrast radiography is
called for only after sufficient evidence of
shunting has been gathered. Of the confirma-
tory radiographic techniques, arterial porto-
graphy or splenoportography are less invasive
and appear to be sufficient to identify shunts
provided the necessary equipment is available.
However, if this is not the case, operative me-
senteric portography is indicated. If surgical li-
gation of the shunt is to be attempted, then
operative portography is definitely indicated.
Medical management only slows the pro-
gressive liver atrophy and fibrosis and ame-
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liorates the clinical signs. If feasible, surgical
ligation of the shunt should be performed to
maximize hepatic function and allow a more
normal life.
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